JK Agri Genetics Limited (BOM:536493)
342.90
+4.80 (1.42%)
At close: Feb 13, 2026
JK Agri Genetics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 1,622 | 1,618 | 1,481 | 2,009 | 2,458 | 2,238 | |
Revenue Growth (YoY) | 10.17% | 9.24% | -26.29% | -18.27% | 9.86% | 24.34% |
Cost of Revenue | 964.43 | 1,009 | 1,005 | 1,231 | 1,335 | 1,235 |
Gross Profit | 657.78 | 608.59 | 475.55 | 778.71 | 1,124 | 1,003 |
Selling, General & Admin | 323.48 | 371.27 | 341.73 | 476.28 | 509.09 | 427.45 |
Other Operating Expenses | 304.62 | 337.49 | 385.81 | 385.56 | 462.18 | 365.19 |
Operating Expenses | 664.9 | 749.1 | 762.19 | 886.41 | 1,006 | 827.92 |
Operating Income | -7.12 | -140.51 | -286.64 | -107.7 | 118 | 175.36 |
Interest Expense | -45.45 | -58.15 | -79.46 | -68.88 | -53.72 | -61.02 |
Interest & Investment Income | 4.37 | 4.37 | 2.62 | 3.01 | 23.11 | 7.33 |
Earnings From Equity Investments | -0.05 | -0.04 | - | - | - | - |
Currency Exchange Gain (Loss) | -0.31 | -0.31 | -0.31 | -0.11 | -0.4 | -3.01 |
Other Non Operating Income (Expenses) | 32.06 | -0.78 | 33.06 | -1.29 | 13.61 | 9.57 |
EBT Excluding Unusual Items | -16.5 | -195.42 | -330.74 | -174.98 | 100.6 | 128.23 |
Gain (Loss) on Sale of Investments | 46.7 | 46.7 | 37.14 | 22.67 | 1.81 | 8.43 |
Gain (Loss) on Sale of Assets | -0.82 | -0.82 | -2.5 | -0.45 | 0.15 | 2.06 |
Other Unusual Items | -8.46 | 124.85 | - | - | - | -38.56 |
Pretax Income | 20.92 | -24.69 | -296.09 | -152.76 | 102.56 | 100.17 |
Income Tax Expense | 15.21 | 0.39 | -87.88 | -44.77 | 25.24 | 28.47 |
Net Income | 5.71 | -25.09 | -208.21 | -107.99 | 77.32 | 71.7 |
Net Income to Common | 5.71 | -25.09 | -208.21 | -107.99 | 77.32 | 71.7 |
Net Income Growth | - | - | - | - | 7.83% | - |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 4 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 4 |
Shares Change (YoY) | -0.13% | - | - | - | 8.02% | 17.74% |
EPS (Basic) | 1.23 | -5.41 | -44.90 | -23.29 | 16.67 | 16.70 |
EPS (Diluted) | 1.23 | -5.41 | -44.90 | -23.29 | 16.67 | 16.70 |
EPS Growth | - | - | - | - | -0.17% | - |
Free Cash Flow | - | 34.22 | 232.69 | 12.46 | -17.24 | 201.73 |
Free Cash Flow Per Share | - | 7.38 | 50.18 | 2.69 | -3.72 | 46.99 |
Dividend Per Share | - | - | - | - | 1.500 | 1.500 |
Gross Margin | 40.55% | 37.62% | 32.11% | 38.76% | 45.71% | 44.83% |
Operating Margin | -0.44% | -8.69% | -19.36% | -5.36% | 4.80% | 7.84% |
Profit Margin | 0.35% | -1.55% | -14.06% | -5.37% | 3.15% | 3.20% |
Free Cash Flow Margin | - | 2.11% | 15.71% | 0.62% | -0.70% | 9.01% |
EBITDA | 54.07 | -100.17 | -274.09 | -93.09 | 132.26 | 190.48 |
EBITDA Margin | 3.33% | -6.19% | -18.51% | -4.63% | 5.38% | 8.51% |
D&A For EBITDA | 61.19 | 40.34 | 12.55 | 14.61 | 14.26 | 15.12 |
EBIT | -7.12 | -140.51 | -286.64 | -107.7 | 118 | 175.36 |
EBIT Margin | -0.44% | -8.69% | -19.36% | -5.36% | 4.80% | 7.84% |
Effective Tax Rate | 72.70% | - | - | - | 24.61% | 28.42% |
Revenue as Reported | 1,706 | 1,669 | 1,556 | 2,035 | 2,499 | 2,269 |
Advertising Expenses | - | 20.02 | 39.24 | 109.83 | 117.74 | 75.02 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.